Deutsch English Français

Contact

EP3560488

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3560488

EP3560488 - COMPOSITIONS FOR TREATING FEMALE SEXUAL DYSFUNCTION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.10.2020 Database last updated on 05.10.2024
Former	The application has been published Status updated on 27.09.2019
Most recent event Tooltip	09.10.2020	Application deemed to be withdrawn	published on 11.11.2020 [2020/46]
Applicant(s)	For all designated states Procare Health Iberia, S.L. Avda. Miguel Hernández 21, Bajo 46450 Benifaió / ES
	[2019/44]
Inventor(s)	01 / LOSA DOMÍNGUEZ, Fernando Clinica Sagrada Familia Torras i Pujalt, 11-29 08022 BARCELONA / ES
	02 / PALACIOS, Santiago Antonio Acuña, 9 28009 MADRID / ES
	03 / GASLAIN, Yann Paseo Tramuntana, 89 00860 CASTELLDEFELS / ES
	[2019/44]
Representative(s)	ZBM Patents - Zea, Barlocci & Markvardsen Rambla de Catalunya, 123 08008 Barcelona / ES
	[N/P]
Former [2019/44]	ZBM Patents - Zea, Barlocci & Markvardsen Plaza Catalunya, 1 2nd floor 08002 Barcelona / ES
Application number, filing date	18382276.6	24.04.2018
	[2019/44]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3560488
	Date:	30.10.2019
	Language:	EN
	[2019/44]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	04.07.2018
Classification	IPC:	A61K9/20, A61K36/16, A61K36/18, A61K36/185, A61K36/48	[2019/44]
	CPC:	A61K9/2004 (EP,KR); A61K36/48 (EP,KR,US); A61K31/4415 (EP,KR,US); A61K31/455 (EP,US); A61K31/51 (EP,US); A61K31/525 (EP,KR,US); (+) A61K33/04 (EP,US); A61K36/16 (EP,KR,US); A61K36/185 (EP,US); A61K36/288 (KR); A61K9/127 (US); A61P15/00 (EP,KR); A61P15/10 (US); A61P15/12 (EP,KR); A61K2300/00 (KR) (-)
	C-Set:	A61K31/4415, A61K2300/00 (EP); A61K31/455, A61K2300/00 (EP); A61K31/51, A61K2300/00 (EP); A61K31/525, A61K2300/00 (EP); (+) A61K33/04, A61K2300/00 (EP); A61K36/16, A61K2300/00 (EP); A61K36/185, A61K2300/00 (EP); A61K36/48, A61K2300/00 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/44]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	KH	Not yet paid
	MA	Not yet paid
	MD	Not yet paid
	TN	Not yet paid
Title	German:	ZUSAMMENSETZUNG ZUR BEHANDLUNG WEIBLICHER SEXUELLER DYSFUNKTION	[2019/44]
	English:	COMPOSITIONS FOR TREATING FEMALE SEXUAL DYSFUNCTION	[2019/44]
	French:	COMPOSITION POUR LE TRAITEMENT DE LA DYSFONCTION SEXUELLE FÉMININE	[2019/44]
Examination procedure	03.06.2020	Application deemed to be withdrawn, date of legal effect [2020/46]
	25.06.2020	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2020/46]
Fees paid	Penalty fee
	Additional fee for renewal fee
	30.04.2020	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO03094943 (INDENA SPA [IT], et al) [Y] 1-15 * example 1 * * claims 1-10 * * page 2, line 18 - line 28 *;
		[Y]US2014154346 (BHASKARAN SUNIL [IN], et al) [Y] 1-15 * claims 1-20 * * examples 1, 2 * * paragraph [0123] - paragraph [0124] *;
		[Y] - ROWLAND D L ET AL, "A REVIEW OF PLANT-DERIVED AND HERBAL APPROACHES TO THE TREATMENT OF SEXUAL DYSFUNCTIONS", JOURNAL OF SEX AND MARITAL THE, BRUNNER-MAZEL, INC, US, (20030101), vol. 29, no. 3, doi:10.1080/00926230390155096, ISSN 0092-623X, pages 185 - 205, XP008072607 [Y] 1-15 * table 3 * * page 191, paragraph 2 - page 192, paragraph 3 * * page 194, paragraph 2 - page 196, paragraph 4 * DOI: http://dx.doi.org/10.1080/00926230390155096
	by applicant	- DAVIS S.R. et al., "Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women", J Sex Med, (20120000), vol. 9, no. 4, pages 1134 - 48
		- SIMON J.A. et al., "Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial", Menopause, (20140000), vol. 21, no. 6, pages 633 - 40
		- AFTAB A. et al., "Flibanserin and its discontents", Arch Womens Ment Health, (20170000), vol. 20, no. 2, doi:doi:10.1007/s00737-016-0693-6, pages 243 - 247, XP036174928 DOI: http://dx.doi.org/10.1007/s00737-016-0693-6
		- ROSEN R et al., "The female sexual function index (FSFI): a multidimensional self- report instrument for the assessment of female sexual function", J Sex Marital Ther, (20000000), vol. 26, pages 191 - 208
		- ROSEN R. et al., "The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function", J Sex Marital Ther, (20000000), vol. 26, pages 191 - 208

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p